Home A reference material for traceability of aspartate aminotransferase (AST) results
Article
Licensed
Unlicensed Requires Authentication

A reference material for traceability of aspartate aminotransferase (AST) results

  • Georges Férard , Françoise Imbert-Bismut , Djamila Messous , Annie Piton , Shigeru Ueda , Thierry Poynard and Jean-Marc Lessinger
Published/Copyright: September 21, 2011

Abstract

Standardization of aspartate aminotransferase (AST) determination is highly desirable for inter-laboratory comparison. Serum AST mean values for 20 patients suffering from viral hepatitis showed an inter-laboratory (n=13) variation of 9.4%. Part of this variation was due to two laboratories using procedures without pyridoxal-5′-phosphate. A traceable AST value was assigned to an enzyme calibrator (EC) through the appropriate International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) primary reference procedure. The EC was commutable for seven routine methods. Common calibration using the EC reduced the inter-laboratory coefficient of variation (CV=5.9% ) and allowed retention of a common reference interval for a set of routine procedures. Calibration made superfluous the expression of results in multiples of the upper reference limit, which increased inter-laboratory variation (CV=18.5%). Furthermore, for 92% of patients, calibration with the EC allowed the correction of misclassifications when taking into account the reference interval of the reference procedure. Use of this EC could be proposed to complete the AST reference system.


Corresponding author: Georges Férard, Laboratoire de Biochimie Appliquée de la Faculté de Pharmacie et Laboratoire du Centre de Traumatologie et d'Orthopédie, Université Louis Pasteur de Strasbourg, 10 avenue A. Baumann, 67403 Illkirch cedex, France Phone: +33-3-88-55-21-07, Fax +33-3-88-66-20-28, E-mail:

References

1 Férard G, Edwards J, Kanno T, Lessinger JM, Moss DW, Schiele F, et al. Inter-assay calibration as a major contribution to the comparability of results in clinical enzymology. Clin Biochem 1998; 31: 489–94. 10.1016/S0009-9120(98)00038-1Search in Google Scholar

2 Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 2002; 40: 635–42. 10.1515/CCLM.2002.110Search in Google Scholar

3 Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin Chem Lab Med 2002; 40: 643–8. 10.1515/CCLM.2002.111Search in Google Scholar

4 Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck FH, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 6. Reference procedure for the measurement of catalytic concentration of γ-glutamyltransferase. Clin Chem Lab Med 2002; 40: 734–8. Search in Google Scholar

5 Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck FH, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate-aminotransferase [L-aspartate:2-oxoglutarate aminotransferase (AST), EC 2.6.1.1]. Clin Chem Lab Med 2002; 40: 725–33. Search in Google Scholar

6 Aoki R, Hirayama T, Ueda S, Imamura S, Misaki H. Development of lyophilized multi-enzyme material as secondary reference material. Clin Chem Lab Med 2002; 40(Suppl): 237. Search in Google Scholar

7 Passing H, Bablok W. A new biometrical procedure for testing the equality of measurement from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709–20. Search in Google Scholar

8 European Parliament and the Council. Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 27 October 1998. Search in Google Scholar

9 Panteghini M, Ceriotti F, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2002; 39: 785–800. Search in Google Scholar

10 Férard G, Imbert-Bismut F, Messous D, Piton A, Abella A, Burnat P, et al. Effet du phosphate de pyridoxal dans la mesure des activités aminotransférases chez les patients avec hépatite virale. Ann Biol Clin 2002; 62: 717–20. Search in Google Scholar

11 Vanderlinde RE. Review of pyridoxal phosphate and the transaminases in liver disease. Ann Clin Lab Sci 1986; 16: 79–93. Search in Google Scholar

12 Diehl AM, Potter J, Boinott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal-5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984; 86: 632–6. 10.1016/S0016-5085(84)80110-9Search in Google Scholar

13 Myara A, Guechot J, Imbert-Bismut F, Lasnier E, Piton A, Voitot H, et al. Harmonization of liver enzyme results: calibration for aminotransferases and gammaglutamyltransferase. J Hepatol 2004; 4: 501–2. 10.1016/j.jhep.2004.04.036Search in Google Scholar

14 Férard G, Edwards J, Kanno T, Lessinger JM, Moss DW, Schiele F, et al. Validation of an enzyme calibrator – an IFCC guideline. Clin Biochem 1998; 31: 495–500. 10.1016/S0009-9120(98)00039-3Search in Google Scholar

15 Eto A, Oishi T, Nakano NI, Chikaura Y. Multienzyme control serum (Seraclear-HE) containing human enzymes from established cell lines and other sources. 3. Evaluation as candidate working enzyme reference material for gamma-glutamyltransferase. Clin Chem 1996; 42: 2008–14. 10.1093/clinchem/42.12.2008Search in Google Scholar

Received: 2005-1-12
Accepted: 2005-3-14
Published Online: 2011-9-21
Published in Print: 2005-5-1

© by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Second Santorini Conference “From Human Genetic Variations to Prediction of Risks and Responses to Drugs and to the Environment”
  2. Expressed genome molecular signatures of heart failure
  3. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice
  4. Alcohol and gene interactions
  5. β-Carotene stimulates chemotaxis of human endothelial progenitor cells
  6. Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages
  7. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients
  8. Apolipoprotein E haplotyping by denaturing high-performance liquid chromatography
  9. Both core and terminal glycosylation alter epitope expression in thyrotropin and introduce discordances in hormone measurements
  10. Do we measure bilirubin correctly anno 2005?
  11. Differences in mortality on the basis of laboratory parameters in an unselected population at the Emergency Department
  12. An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man™ probes
  13. A reference material for traceability of aspartate aminotransferase (AST) results
  14. Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis
  15. Multicenter evaluation of the analytical and clinical performance of the Elecsys ® S100 immunoassay in patients with malignant melanoma
  16. Guidelines for sampling, measuring and reporting ionized magnesium in undiluted serum, plasma or blood: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division, Committee on Point of Care Testing
  17. Evaluation of the Quantase™ neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis
Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.095/html
Scroll to top button